RA is characterized by an increase in the amount of antiapoptotic proteins, Bcl-2 and Mcl-1, SUMO1, FLIP, as well as by somatic mutation of the p53 protein gene, which probably contributes to the inhibition of synovicyte apoptosis [331,332,333,397]. This evidence concerns the gene BCL2 and rheumatoid arthritis.